DXCM vs. NVMI
DXCM (DexCom, Inc.) and NVMI (Nova Ltd) are both stocks. DXCM operates in Diagnostics & Research (Healthcare), while NVMI operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, DXCM returned 13.66%/yr vs 42.36%/yr for NVMI. Their 0.20 correlation means their historical movements had little consistent relationship.
Performance
DXCM vs. NVMI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 25.73% return, which is significantly higher than NVMI's 19.03% return. Over the past 10 years, DXCM has underperformed NVMI with an annualized return of 13.66%, while NVMI has yielded a comparatively higher 42.36% annualized return.
DXCM
- 1D
- 11.95%
- 1M
- 21.19%
- 6M
- 14.25%
- YTD
- 25.73%
- 1Y
- 3.32%
- 3Y*
- -11.89%
- 5Y*
- -8.33%
- 10Y*
- 13.66%
- ALL TIME*
- 16.87%
NVMI
- 1D
- -0.81%
- 1M
- -22.23%
- 6M
- -14.63%
- YTD
- 19.03%
- 1Y
- 48.85%
- 3Y*
- 45.70%
- 5Y*
- 31.93%
- 10Y*
- 42.36%
- ALL TIME*
- 12.41%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
DXCM DexCom, Inc. | $381.17M | $359.84M | $403.63M |
NVMI Nova Ltd | $244.73M | $256.96M | $251.18M |
DXCM vs. NVMI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 25.73% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
NVMI Nova Ltd | 19.03% | 66.74% | 43.35% | 68.21% | -44.25% | 107.51% | 86.62% | 66.07% | -12.08% | 96.88% |
Correlation
The correlation between DXCM and NVMI is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.02 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2005 | 0.20 |
The correlation between DXCM and NVMI shifts across timeframes, from 0.02 (1 year) to 0.26 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
DXCM:
$32.20B
NVMI:
$12.42B
DXCM:
$2.51
NVMI:
$7.85
DXCM:
33.22
NVMI:
49.78
DXCM:
0.79
NVMI:
1.73
DXCM:
6.68
NVMI:
14.54
DXCM:
12.47
NVMI:
9.70
DXCM:
$4.97B
NVMI:
$902.53M
DXCM:
$3.12B
NVMI:
$518.59M
DXCM:
$1.41B
NVMI:
$293.89M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. NVMI — Risk / Return Rank
DXCM
NVMI
DXCM vs. NVMI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Nova Ltd (NVMI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | NVMI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.95 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.17 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.10 | 1.25 | -1.15 |
| Martin ratioReturn relative to average drawdown | 0.19 | 4.35 | -4.16 |
Loading charts...
Drawdowns
DXCM vs. NVMI - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, roughly equal to the maximum NVMI drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for DXCM and NVMI.
Loading charts...
Drawdown Indicators
| DXCM | NVMI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -98.22% | +3.61% |
Max Drawdown (1Y)Largest decline over 1 year | -33.33% | -39.42% | +6.09% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -40.79% | -20.16% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -52.76% | -13.56% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -52.76% | -13.56% |
Current DrawdownCurrent decline from peak | -48.75% | -35.46% | -13.29% |
Average DrawdownAverage peak-to-trough decline | -36.14% | -51.60% | +15.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.53% | 11.25% | +6.28% |
Volatility
DXCM vs. NVMI - Volatility Comparison
The current volatility for DexCom, Inc. (DXCM) is 15.95%, while Nova Ltd (NVMI) has a volatility of 19.26%. This indicates that DXCM experiences smaller price fluctuations and is considered to be less risky than NVMI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | NVMI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.95% | 19.26% | -3.31% |
Volatility (6M)Calculated over the trailing 6-month period | 29.74% | 47.21% | -17.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.91% | 59.08% | -16.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.22% | 48.96% | -1.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.66% | 44.23% | +4.43% |
Dividends
DXCM vs. NVMI - Dividend Comparison
Neither DXCM nor NVMI has paid dividends to shareholders.
Financials
DXCM vs. NVMI - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and Nova Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. NVMI - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a gross profit of 830.00M and revenue of 1.31B. Therefore, the gross margin over that period was 63.4%.
NVMI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nova Ltd reported a gross profit of 135.69M and revenue of 235.31M. Therefore, the gross margin over that period was 57.7%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported an operating income of 318.30M and revenue of 1.31B, resulting in an operating margin of 24.3%.
NVMI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nova Ltd reported an operating income of 70.84M and revenue of 235.31M, resulting in an operating margin of 30.1%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a net income of 249.10M and revenue of 1.31B, resulting in a net margin of 19.0%.
NVMI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nova Ltd reported a net income of 69.26M and revenue of 235.31M, resulting in a net margin of 29.4%.
Frequently Asked Questions
DXCM and NVMI have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVMI has higher volatility (19.26%) compared to DXCM (15.95%). In terms of maximum drawdown, DXCM dropped -94.61% vs NVMI's -98.22%.
NVMI currently has the higher Sharpe Ratio (0.83 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and NVMI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer